Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. [electronic resource]
Producer: 20050920Description: 5960-72 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Aged, 80 and over
- Anemia
- Breast Neoplasms -- drug therapy
- Epoetin Alfa
- Erythropoietin -- adverse effects
- Female
- Hematinics -- adverse effects
- Hemoglobins -- analysis
- Humans
- Injections, Subcutaneous
- Middle Aged
- Neoplasm Metastasis
- Placebos
- Quality of Life
- Recombinant Proteins
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.